Hepatopulmonary Syndrome After Radiofrequency Ablation of Recurrent Intrahepatic Cholangiocarcinoma: a Case Report

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2019 May 2

PMID 31040688

Citations 1

Authors

Yu Wang

Kuansheng Ma

Ai Zhong

Qing Xiong

Jian Chen

Affiliations

Soon will be listed here.

Abstract

Background: Radiofrequency ablation (RFA) is one of the definitive treatment modalities for liver cancer and has been increasingly used in the scenario of small-sized liver cancer. It is generally believed that RFA is minimally invasive and associated with a favorable safety profile in liver cancer patients. However, this interventional technique is subject to some morbidity in high-risk patients, such as those with complicating cirrhosis or a liver cancer located at a refractory segment.

Methods: Herein, we report the case of a middle-aged woman who developed acute liver failure with a complicating respiratory failure after RFA of recurrent intrahepatic cholangiocarcinoma.

Results: A diagnosis of hepatopulmonary syndrome was established. The patient was hospitalized in the intensive care unit for mechanical ventilation. Finally, the patient recovered from an eventful clinical course and survived free of recurrence until the last follow-up visit at 1 year after the discharge.

Conclusion: Our case report warns that hepatopulmonary syndrome, a less common morbidity secondary to liver cancer RFA, should require timely identification and appropriate management due to its life-threatening outcome.

Citing Articles

Laparoscopic versus open surgery for perihilar cholangiocarcinoma: a multicenter propensity score analysis of short- term outcomes.

Wang M, Qin T, Zhang H, Li J, Deng X, Zhang Y BMC Cancer. 2023; 23(1):394.

PMID: 37138243 PMC: 10157952. DOI: 10.1186/s12885-023-10783-9.

References

Wood T, Rose D, Chung M, Allegra D, Foshag L, Bilchik A . Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol. 2000; 7(8):593-600. DOI: 10.1007/BF02725339. View

Keltner J, Donegan E, Hynson J, Shapiro W . Acute renal failure after radiofrequency liver ablation of metastatic carcinoid tumor. Anesth Analg. 2001; 93(3):587-9. DOI: 10.1097/00000539-200109000-00011. View

Yamagami T, Nakamura T, Kato T, Matsushima S, Iida S, Nishimura T . Skin injury after radiofrequency ablation for hepatic cancer. AJR Am J Roentgenol. 2002; 178(4):905-7. DOI: 10.2214/ajr.178.4.1780905. View

Shibata T, Shibata T, Maetani Y, Kubo T, Itoh K, Togashi K . Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol. 2004; 15(11):1323-7. DOI: 10.1097/01.RVI.0000132297.97113.C4. View

Jansen M, van Duijnhoven F, van Hillegersberg R, Rijken A, van Coevorden F, van der Sijp J . Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg. 2005; 92(10):1248-54. DOI: 10.1002/bjs.5059. View

Palma D, Fallon M . The hepatopulmonary syndrome. J Hepatol. 2006; 45(4):617-25. DOI: 10.1016/j.jhep.2006.07.002. View

Falco A, Orlando D, Sciarra R, Sergiacomo L . A case of biliary gastric fistula following percutaneous radiofrequency thermal ablation of hepatocellular carcinoma. World J Gastroenterol. 2007; 13(5):804-5. PMC: 4066018. DOI: 10.3748/wjg.v13.i5.804. View

Almeida J, Riordan S, Liu J, Galhenage S, Kim R, Bihari D . Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome. Eur J Gastroenterol Hepatol. 2007; 19(4):341-6. DOI: 10.1097/MEG.0b013e328014a3bf. View

Kasugai H, Osaki Y, Oka H, Kudo M, Seki T . Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Oncology. 2007; 72 Suppl 1:72-5. DOI: 10.1159/000111710. View

10.

Rodriguez-Roisin R, Krowka M . Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med. 2008; 358(22):2378-87. DOI: 10.1056/NEJMra0707185. View

11.

Fallon M, Krowka M, Brown R, Trotter J, Zacks S, Roberts K . Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008; 135(4):1168-75. PMC: 2824882. DOI: 10.1053/j.gastro.2008.06.038. View

12.

Tanikella R, Philips G, Faulk D, Kawut S, Fallon M . Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transpl. 2008; 14(8):1199-203. PMC: 2834782. DOI: 10.1002/lt.21482. View

13.

Kong W, Zhang W, Qiu Y, Zhou T, Qiu J, Zhang W . Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients. World J Gastroenterol. 2009; 15(21):2651-6. PMC: 2691498. DOI: 10.3748/wjg.15.2651. View

14.

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

15.

Pompili M, Riccardi L, Garcovich M, Sollazzi L, Seccia A, Rapaccini G . Severe skin burn at needle entry point complicating radiofrequency ablation for hepatocellular carcinoma. Ultraschall Med. 2011; 33(7):E359-E360. DOI: 10.1055/s-0031-1281662. View

16.

Feng K, Yan J, Li X, Xia F, Ma K, Wang S . A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012; 57(4):794-802. DOI: 10.1016/j.jhep.2012.05.007. View

17.

Zhang J, Fallon M . Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol. 2012; 9(9):539-49. PMC: 10963041. DOI: 10.1038/nrgastro.2012.123. View

18.

Jiang K, Su M, Zhang W, Zhao X, Wang J, Dong J . Complete radiofrequency ablation of hepatolithiasis-associated cholangiocarcinoma and successful management of post-ablation bronchobiliary fistula. Cell Biochem Biophys. 2013; 68(3):555-9. DOI: 10.1007/s12013-013-9737-y. View

19.

Nayyar D, Man H, Granton J, Gupta S . Defining and characterizing severe hypoxemia after liver transplantation in hepatopulmonary syndrome. Liver Transpl. 2013; 20(2):182-90. DOI: 10.1002/lt.23776. View

20.

Abbott D, Sohn V, Hanseman D, Curley S . Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases. J Surg Oncol. 2013; 109(6):516-20. DOI: 10.1002/jso.23539. View